Clinical Trial Update: A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of SHR-1314 for adults with active psoriatic arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• SHR-1314 (SHR-1314)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Psoriatic Arthritis | Phase 3 | Status: RECRUITING